| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 27, 2013 | Alpha Street Research | Hunter Orr | IRWD - Ironwood Pharmaceuticals Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report | 9 | $24 | | May 24, 2013 | S&P Capital IQ Quantitative Report | N/A | Ironwood Pharmaceuticals | 6 | $69 | | May 24, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Ironwood Pharmaceuticals Incorporation | 40 | $460 | | May 24, 2013 | Pechala's Reports | Frantisek Pechala | IRONWOOD PHARMACEUTICALS LTD (IRWD) 12-months forecast | 1 | $15 | | May 23, 2013 | New Constructs, LLC | N/A | IRWD: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 23, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-drugs | 18 | $207 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: IRONWOOD PHARMA -- IRWD | 1 | $11.50 | | May 23, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: RDY , ELN , ENDP , IPXL , IRWD , MYL , VRX , WCRX -- DRUGS | 3 | $34.50 | | May 23, 2013 | Jefferson Research | N/A | Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of IRONWOOD PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 11 | $20 | | May 22, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for IRWD | 11 | $126.50 |
|
View All Reports for IRWD ... |
|
|
0.31(2.48%) May 24, 4:00PM EDT|After Hours
:
12.52